Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma
Clinical trial NCT01468311 · TERMINATED
Trial details
- NCT number
- NCT01468311
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-11
- Primary completion
- 2014-11-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.